BVCLF (BATM Advanced Communications) ROE %: -35.13% (As of Dec. 2025)


BVCLF BATM Advanced Communications Ltd BVCLF
40 GF Score
Price $0.00
! 5 Warning Signs
View Full Analysis

What is BATM Advanced Communications ROE %?

BATM Advanced Communications BVCLF 40 ROE % is -35.13% as of Dec. 2025. GuruFocus rates BVCLF with a GF Score™ of 40/100. The stock has 5 warning signs investors should review. Among 799 Medical Devices & Instruments companies, BATM Advanced Communications ranks worse than 73.59% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BATM Advanced Communications's annualized net income for the quarter that ended in Dec. 2025 was $-29.2 Mil. BATM Advanced Communications's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was $83.2 Mil. Therefore, BATM Advanced Communications's annualized ROE % for the quarter that ended in Dec. 2025 was -35.13%.

The historical rank and industry rank for BATM Advanced Communications's ROE % or its related term are showing as below:

BVCLF' s ROE % Range Over the Past 10 Years
Min: -22.2   Med: 0.24   Max: 11.53
Current: -20.73

During the past 13 years, BATM Advanced Communications's highest ROE % was 11.53%. The lowest was -22.20%. And the median was 0.24%.

BVCLF's ROE % is ranked worse than
73.59% of 799 companies
in the Medical Devices & Instruments industry
Industry Median: 2.42 vs BVCLF: -20.73

BATM Advanced Communications  (OTCPK:BVCLF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-29.218/83.168
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-29.218 / 125.672)*(125.672 / 132.7245)*(132.7245 / 83.168)
=Net Margin %*Asset Turnover*Equity Multiplier
=-23.25 %*0.9469*1.5959
=ROA %*Equity Multiplier
=-22.02 %*1.5959
=-35.13 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-29.218/83.168
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-29.218 / 23.608) * (23.608 / -2.938) * (-2.938 / 125.672) * (125.672 / 132.7245) * (132.7245 / 83.168)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= -1.2376 * -8.0354 * -2.34 % * 0.9469 * 1.5959
=-35.13 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


BATM Advanced Communications ROE % Related Terms


BATM Advanced Communications ROE % Historical Data

* Premium members only.

The historical data trend for BATM Advanced Communications's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BATM Advanced Communications ROE % Chart

BATM Advanced Communications Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.47 0.20 -0.16 -20.80 -22.97

BATM Advanced Communications Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 0.00 -42.14 -7.65 -35.13

BVCLF vs ISRG, BDX, MDLN: ROE % Comparison

For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BATM Advanced Communications ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's ROE % distribution charts can be found below:

* The bar in red indicates where BATM Advanced Communications's ROE % falls into.


BVCLF
40GF Score
BATM Advanced Communications Ltd BVCLF
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BATM Advanced Communications ROE % Calculation

BATM Advanced Communications's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-18.335/( (94.063+65.567)/ 2 )
=-18.335/79.815
=-22.97 %

BATM Advanced Communications's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-29.218/( (100.769+65.567)/ 2 )
=-29.218/83.168
=-35.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -35.13% mean?
BATM Advanced Communications (BVCLF) has a ROE % of -35.13% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BATM Advanced Communications and its competitors. According to the industry distribution chart, BATM Advanced Communications ranks #588 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 73.6%.
Is BATM Advanced Communications' ROE % too high?
BATM Advanced Communications' current ROE % is -35.13%. Based on the distribution chart, BATM Advanced Communications ranks #588 out of 799 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, BATM Advanced Communications has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #588 out of 799 companies for ROE %. This places BATM Advanced Communications in the lower half of its industry. The industry median ROE % is 2.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current ROE % is -35.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
BATM Advanced Communications (BVCLF) has a current ROE % of -35.13%. The current ROE % is -35.13%. BATM Advanced Communications' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For BATM Advanced Communications (BVCLF), the current ROE % is -35.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BATM Advanced Communications Business Description

Address Ha’harash Street, P.O.B. 7318, Nave Ne\'eman Industrial Area 4, Hod Hasharon, ISR, 4524075
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
40GF Score

Get the complete analysis for BVCLF

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price